David I. Bernstein, MD home Request a consultation

Publications, research and honors

More than four decades of peer-reviewed research, national practice guidelines and federally funded investigation in allergy, asthma and occupational lung disease

275PubMed-indexed publications, 1982–2026
73as first author; 64 as senior author
16national practice parameters, guidelines and consensus reports
$3.1MNIOSH research funding as Principal Investigator

Honors and recognition

2025
Special Recognition Award, American Academy of Allergy, Asthma & Immunology (shared with Jonathan A. Bernstein, MD and the late I. Leonard Bernstein, MD) · AAAAI
2022
Distinguished Fellow Award, American College of Allergy, Asthma and Immunology · ACAAI
2019
Distinguished Clinician Award, American Academy of Allergy, Asthma & Immunology · AAAAI
2004
Alpha Omega Alpha Honor Medical Society · UC Research Directory
1988–1991
Special Emphasis Research Career Award (K Award), National Institute for Occupational Safety and Health · UC Research Directory
1980–1981
National Institutes of Health Research Fellowship Award · UC Research Directory
Also
Outstanding Alumni Award, University of Cincinnati College of Medicine. Fellow of the American Academy of Allergy, Asthma & Immunology (FAAAAI), the American College of Allergy, Asthma and Immunology (FACAAI) and the American College of Physicians (FACP). · Advanced Allergy Services

Leadership and service

Certification boards
Former Member and Chair, American Board of Allergy and Immunology.
Professional societies
Former Board of Regents, American College of Allergy, Asthma and Immunology. Former member, Joint Task Force on Practice Parameters in Allergy.
Patient safety
Director, North American Immunotherapy Safety Surveillance Study (AAAAI/ACAAI), since 2008.
Medical education
Director, University of Cincinnati Allergy Fellowship Training Program, 1982–2019; now Associate Director. Principal Investigator, NIAID allergy-immunology training grant (T32), 2004–2019.
Editorial
Editorial boards of The Journal of Allergy and Clinical Immunology: In Practice and Journal of Asthma. Author, Occupational Asthma, Immunology and Allergy Clinics of North America (Elsevier, 2011).
Board certification
American Board of Allergy and Immunology (1983); American Board of Internal Medicine (1980); Diagnostic Laboratory Immunology (1988).

Federal research funding

SponsorProjectYearsRole
NIOSHGenetic Susceptibility for Occupational Asthma (R01 OH008795)2006–2017Principal Investigator
NIOSHChemokine Biomarkers of Diisocyanate-Induced Occupational Asthma (R01 OH03519)1999–2004Principal Investigator
NIAIDImmunology/Allergy Fellowship Training Grant (T32 AI060515)2004–2019Principal Investigator
NIEHSDiesel, Allergens and Gene Interaction and Childhood Atopy (CCAAPS)2001–2012Co-Investigator / Collaborator
NIEHSNeurobehavioral and Neuroimaging Effects of Traffic Exposure in Children2012–2017Collaborator
NIEHSTraffic-Related Air Pollutants and the Respiratory Tract Microbiome in Children2015–2017Collaborator

Source: University of Cincinnati Research Directory. In addition, Dr. Bernstein has served as a principal investigator on hundreds of industry-sponsored clinical trials of new treatments for asthma, allergy, COPD and atopic dermatitis.

National practice parameters and guidelines

Co-authored standards that allergists across the United States use to diagnose and treat patients.

  1. Bernstein DI. Aeroallergen immunotherapy update: Developments since the third Practice Parameter. Allergy Asthma Proc 2025;46(6):450-454. PubMed · DOI
  2. Golden DB, Bernstein DI, Freeman TM, Tracy JM, Lang DM, Nicklas RA. AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report. Ann Allergy Asthma Immunol 2017;118(3):283-285. PubMed · DOI
  3. Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, … Bernstein DI, et al.. Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol 2017;118(3):276-282.e2. PubMed · DOI
  4. Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, … Bernstein DI, et al.. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol 2017;119(6):489-511.e41. PubMed · DOI
  5. Fonacier L, Bernstein DI, Pacheco K, Holness DL, Blessing-Moore J, Khan D, et al.. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract 2015;3(3 Suppl):S1-39. PubMed · DOI
  6. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, … Bernstein DI, et al.. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015;136(5):1186-205.e1-78. PubMed · DOI
  7. Li JT, Bernstein DI, Calderon MA, Casale TB, Cox L, Passalacqua G, et al.. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report. J Allergy Clin Immunol 2015;137(2):369-76. PubMed · DOI
  8. Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, et al.. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012;130(1):25-43. PubMed · DOI
  9. Portnoy J, Kennedy K, Sublett J, Phipatanakul W, Matsui E, Barnes C, … Bernstein DI, et al.. Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol 2012;108(4):223.e1-15. PubMed · DOI
  10. Greenhawt MJ, Li JT, Bernstein DI, Blessing-Moore J, Cox L, Khan D, et al.. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Ann Allergy Asthma Immunol 2011;106(1):11-6. PubMed · DOI
  11. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, … Bernstein DI, et al.. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2010;127(1 Suppl):S1-55. PubMed · DOI
  12. Weiler JM, Anderson SD, Randolph C, Bonini S, Craig TJ, Pearlman DS, … Bernstein DI, et al.. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105(6 Suppl):S1-47. PubMed · DOI
  13. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al.. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126(3):477-80.e1-42. PubMed · DOI
  14. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al.. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008;100(3 Suppl 3):S1-148. PubMed · DOI
  15. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al.. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl):S1-84. PubMed · DOI
  16. Bernstein DI, Zeiss CR. Guidelines for preparation and characterization of chemical-protein conjugate antigens. Report of the Subcommittee on Preparation and Characterization of Low Molecular Weight Antigens. J Allergy Clin Immunol 1989;84(5 Pt 2):820-2. PubMed · DOI

Complete bibliography

275 publications

2026

  1. Bernstein DI, Talreja N, Casale TB, Li HH, Kaliner MA, Lowenthal R, et al.. Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria. J Allergy Clin Immunol Pract 2026;14(5):1184-1189. PubMed · DOI
  2. Epstein T, Bernstein DI. Immunotherapy in Allergic and Mixed Rhinitis. Immunol Allergy Clin North Am 2026;46(1):111-124. PubMed · DOI
  3. Oppenheimer J, Casale TB, Spergel JM, Bernstein DI, Camargo CA, Ellis AK, et al.. Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis. J Allergy Clin Immunol Pract 2026;14(4):837-845.e3. PubMed · DOI

2025

  1. Bernstein DI. Aeroallergen immunotherapy update: Developments since the third Practice Parameter. Allergy Asthma Proc 2025;46(6):450-454. PubMed · DOI
  2. Bernstein DI, Casale TB, Tanimoto S. Authors' response. Ann Allergy Asthma Immunol 2025;135(3):350. PubMed · DOI
  3. Bernstein DI, Blaiss M, Dellon ES, Rance K. Benefits of Epinephrine for Anaphylaxis Outweigh Potential Harm-A Safety Review. J Allergy Clin Immunol Pract 2025;13(12):3188-3194. PubMed · DOI
  4. Bernstein DI. Can central registries adequately track severe adverse reactions to allergen immunotherapy?. Ann Allergy Asthma Immunol 2025;134(6):628-629. PubMed · DOI
  5. Bernstein DI. Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps. Curr Opin Allergy Clin Immunol 2025;25(6):488-492. PubMed · DOI
  6. Casale TB, Ellis AK, Camargo CA, Spergel JM, Bernstein DI, Oppenheimer J, et al.. Effects of induced allergic rhinitis on endogenous epinephrine. Ann Allergy Asthma Immunol 2025;135(2):235-237. PubMed · DOI
  7. Epstein TG, Berendts K, Bernstein DI. Impact of Dose Adjustment After Gaps in Subcutaneous Immunotherapy: Update From the North American Immunotherapy Surveillance Study (2008-2023). J Allergy Clin Immunol Pract 2025;14(1):253-259.e2. PubMed · DOI
  8. Casale TB, Spergel JM, Bernstein DI, Tanimoto S. Real-world data on the effectiveness of neffy in clinical practice. Ann Allergy Asthma Immunol 2025;135(6):710-711. PubMed · DOI

2024

  1. Stranzl T, Bernstein DI, Matsuoka T, Durham S, Maekawa Y, Sejer Andersen P, et al.. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions. Allergy Asthma Proc 2024;45(4):232-239. PubMed · DOI
  2. Bernstein DI, Pacheco K, Lemiere C. How Allergists Can Perform an Occupational History in Every Patient. J Allergy Clin Immunol Pract 2024;12(8):1951-1958. PubMed · DOI
  3. Greenhawt M, Lieberman J, Blaiss M, Bernstein DI, Oppenheimer J, DuBuske L, et al.. Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults. J Allergy Clin Immunol Pract 2024;12(12):3274-3282.e2. PubMed · DOI
  4. Lemiere C, Bernstein DI. Recognition and Management of Occupational Lung Diseases Associated With Environmental Changes. J Allergy Clin Immunol Pract 2024;12(8):2008-2009. PubMed · DOI
  5. Nelson HS, Bernstein DI, Biedermann T, Nolte H. Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis. Allergy Asthma Proc 2024;45(1):33-36. PubMed · DOI
  6. Bahna SL, Assa'ad AH, Bellanti JA, Bernstein DI, Davis CM, Greenberger PA, et al.. Where is academic medicine going?: Part 1. Medical education and research. Ann Allergy Asthma Immunol 2024;133(3):242-243. PubMed · DOI
  7. Bahna SL, Assa'ad AH, Bellanti JA, Bernstein DI, Davis CM, Greenberger PA, et al.. Where is academic medicine going?: Part 2. Academic career and patient care. Ann Allergy Asthma Immunol 2024;133(4):364-365. PubMed · DOI

2023

  1. Nolte H, Calderon MA, Bernstein DI, Roberts G, Azuma R, Juhl RG, et al.. Anaphylaxis in Clinical Trials of Sublingual Immunotherapy Tablets. J Allergy Clin Immunol Pract 2023;12(1):85-95.e4. PubMed · DOI
  2. Horn A, Bernstein DI, Okubo K, Dalgaard T, Hels O, Sørensen HF, et al.. House dust mite sublingual immunotherapy tablet safety in adolescents with allergic rhinoconjunctivitis: Worldwide clinical trial results. Ann Allergy Asthma Immunol 2023;130(6):797-804.e2. PubMed · DOI
  3. Bernstein DI, Khan N, Epstein TG. Reply to "Does hydroxychloroquine work for chronic spontaneous urticaria?". J Allergy Clin Immunol Pract 2023;11(6):1983-1984. PubMed · DOI
  4. Schmidlin KA, Bernstein DI. Safety of allergen immunotherapy in children. Curr Opin Allergy Clin Immunol 2023;23(6):514-519. PubMed · DOI

2022

  1. Siler TM, Jain R, Collison K, Sharma R, Sutton L, Rees J, … Bernstein DI, et al.. Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease. PLoS One 2022;17(8):e0273170. PubMed · DOI
  2. Khan N, Epstein TG, DuBuske I, Strobel M, Bernstein DI. Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study. J Allergy Clin Immunol Pract 2022;10(12):3300-3305. PubMed · DOI
  3. Eapen AA, Parameswaran S, Forney C, Edsall LE, Miller D, Donmez O, … Bernstein DI, et al.. Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis. PLoS Genet 2022;18(5):e1009973. PubMed · DOI
  4. Calderon MA, Casale TB, Nelson HS, Bacharier LB, Bansal P, Bernstein DI, et al.. Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States. J Allergy Clin Immunol Pract 2022;11(4):1100-1115. PubMed · DOI
  5. Bernstein DI, Berendts K. Is allergy immunotherapy-induced anaphylaxis still a real problem?. Curr Opin Allergy Clin Immunol 2022;22(6):409-412. PubMed · DOI
  6. Bernstein DI, Epstein TG. Managing risk of anaphylaxis in patients receiving allergen immunotherapy: Assessing benefit versus risk. J Allergy Clin Immunol 2022;149(3):884-886. PubMed · DOI
  7. Bernstein DI, Epstein TG. Safety of subcutaneous allergen immunotherapy. Allergy Asthma Proc 2022;43(4):267-271. PubMed · DOI
  8. Dhamija Y, Epstein TEG, Bernstein DI. Systemic Allergic Reactions and Anaphylaxis Associated with Allergen Immunotherapy. Immunol Allergy Clin North Am 2022;42(1):105-119. PubMed · DOI

2021

  1. Bernstein DI, Würtzen PA, DuBuske L, Blaiss MS, Ellis AK, Weber RW, et al.. Allergy to oak pollen in North America. Allergy Asthma Proc 2021;42(1):43-54. PubMed · DOI
  2. Ellis AK, Gagnon R, Bernstein DI, Nolte H. Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis. Allergy Asthma Clin Immunol 2021;17(1):127. PubMed · DOI
  3. Epstein TG, Murphy-Berendts K, Liss GM, Bernstein DI. Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma. Ann Allergy Asthma Immunol 2021;127(1):64-69.e1. PubMed · DOI

2020

  1. Schmidlin K, Sani S, Bernstein DI, Fonacier L. A Hands-on Approach to Contact Dermatitis and Patch Testing. J Allergy Clin Immunol Pract 2020;8(6):1883-1893. PubMed · DOI
  2. Kroner JW, Baatyrbek Kyzy A, Burkle JW, Martin LJ, LeMasters GK, Bernstein DI, et al.. Atopic dermatitis independently increases sensitization above parental atopy: The MPAACH study. J Allergy Clin Immunol 2020;145(5):1464-1466. PubMed · DOI
  3. Calderon MA, Waserman S, Bernstein DI, Demoly P, Douglass J, Gagnon R, et al.. Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report. J Allergy Clin Immunol Pract 2020;8(9):2920-2936.e1. PubMed · DOI
  4. Nolte H, Bernstein DI, Nelson HS, Ellis AK, Kleine-Tebbe J, Lu S. Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial. J Allergy Clin Immunol Pract 2020;8(7):2322-2331.e5. PubMed · DOI
  5. Lemiere C, Bernstein DI. Occupational Allergic Diseases: High Disease Burden Yet Frequently Overlooked. J Allergy Clin Immunol Pract 2020;8(10):3340-3341. PubMed · DOI
  6. Bernstein DI, Epstein TEG. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy. Allergy Asthma Proc 2020;41(2):108-111. PubMed · DOI
  7. Sánchez-Borges M, Bernstein DI, Calabria C. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors. Immunol Allergy Clin North Am 2020;40(1):25-39. PubMed · DOI

2019

  1. Epstein TG, Liss GM, Berendts KM, Bernstein DI. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors. J Allergy Clin Immunol Pract 2019;7(6):1996-2003.e1. PubMed · DOI
  2. James C, Bernstein DI, Cox J, Ryan P, Wolfe C, Jandarov R, et al.. HEPA filtration improves asthma control in children exposed to traffic-related airborne particles. Indoor Air 2019;30(2):235-243. PubMed · DOI
  3. Johansson E, Biagini Myers JM, Martin LJ, He H, Ryan P, LeMasters GK, … Bernstein DI, et al.. Identification of two early life eczema and non-eczema phenotypes with high risk for asthma development. Clin Exp Allergy 2019;49(6):829-837. PubMed · DOI
  4. Hassoun Y, Stevenson MR, Bernstein DI. Idiopathic postprandial diarrhea responsive to antihistamines. Ann Allergy Asthma Immunol 2019;123(4):407-409. PubMed · DOI
  5. Mahler V, Esch RE, Kleine-Tebbe J, Lavery WJ, Plunkett G, Vieths S, … Bernstein DI, et al.. Reply. J Allergy Clin Immunol 2019;144(4):1140-1141. PubMed · DOI
  6. Hassoun Y, James C, Bernstein DI. The Effects of Air Pollution on the Development of Atopic Disease. Clin Rev Allergy Immunol 2019;57(3):403-414. PubMed · DOI
  7. Mahler V, Esch RE, Kleine-Tebbe J, Lavery WJ, Plunkett G, Vieths S, … Bernstein DI, et al.. Understanding differences in allergen immunotherapy products and practices in North America and Europe. J Allergy Clin Immunol 2019;143(3):813-828. PubMed · DOI
  8. Brooks CC, Martin LJ, Pilipenko V, He H, LeMasters GK, Lockey JE, … Bernstein DI, et al.. genetic variation increases asthma risk in children with secondhand smoke exposure. J Asthma 2019;58(3):284-292. PubMed · DOI

2018

  1. Biagini Myers JM, Schauberger E, He H, Martin LJ, Kroner J, Hill GM, … Bernstein DI, et al.. A Pediatric Asthma Risk Score to better predict asthma development in young children. J Allergy Clin Immunol 2018;143(5):1803-1810.e2. PubMed · DOI
  2. Dao A, Bernstein DI. Authors' response. Ann Allergy Asthma Immunol 2018;121(4):513. PubMed · DOI
  3. Bernstein DI, Lummus ZL, Kesavalu B, Yao J, Kottyan L, Miller D, et al.. Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma. J Allergy Clin Immunol 2018;142(3):959-969. PubMed · DOI
  4. Perez Ramirez L, Wendroth H, Martin LJ, Pilipenko VV, He H, Kroner J, … Bernstein DI, et al.. High number of early respiratory infections in association with allergic sensitization to mold promotes childhood asthma. J Allergy Clin Immunol 2018;141(5):1921-1924.e4. PubMed · DOI
  5. Nolte H, Bernstein DI, Sussman GL, Svanholm Fogh B, Lu S, Husøy B, et al.. Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet. J Allergy Clin Immunol Pract 2018;6(6):2081-2086.e1. PubMed · DOI
  6. Dao A, Bernstein DI. Occupational exposure and asthma. Ann Allergy Asthma Immunol 2018;120(5):468-475. PubMed · DOI
  7. Mathur SK, Bernstein DI. On the Road to Improving Asthma Outcomes in Older Adults: The Phenotyping of Asthma in Older Adults. J Allergy Clin Immunol Pract 2018;6(1):250-251. PubMed · DOI
  8. Bernstein DI, Kleine-Tebbe J, Nelson HS, Bardelas JA, Sussman GL, Lu S, et al.. SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration. Ann Allergy Asthma Immunol 2018;121(1):105-110. PubMed · DOI
  9. Nolte H, Bernstein DI, Kleine-Tebbe J, Fejerskov PA, Li Q, Lu S, et al.. Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round. J Allergy Clin Immunol Pract 2018;6(5):1758-1760.e1. PubMed · DOI

2017

  1. Bernstein DI, Bardelas JA, Svanholm Fogh B, Kaur A, Li Z, Nolte H. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice. Postgrad Med 2017;129(6):590-597. PubMed · DOI
  2. Golden DB, Bernstein DI, Freeman TM, Tracy JM, Lang DM, Nicklas RA. AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report. Ann Allergy Asthma Immunol 2017;118(3):283-285. PubMed · DOI
  3. Golden DBK, Bernstein DI, Freeman TM, Tracy JM, Lang DM, Nicklas RA. AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report. J Allergy Clin Immunol Pract 2017;5(2):330-332. PubMed · DOI
  4. Bernstein DI, Wasserman SI, Thompson WP, Freeman TM. ABAI's MOC Assessment of Knowledge Program Matures: Adding Value with Continuous Learning and Assessment. J Allergy Clin Immunol Pract 2017;5(1):80-83. PubMed · DOI
  5. Nelson HS, Calderon MA, Bernstein DI, Casale TB, Durham SR, Andersen JS, et al.. Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles. Curr Allergy Asthma Rep 2017;17(3):18. PubMed · DOI
  6. James C, Bernstein DI. Allergen immunotherapy: an updated review of safety. Curr Opin Allergy Clin Immunol 2017;17(1):55-59. PubMed · DOI
  7. Caperton C, Bernstein DI. Contact Dermatitis. J Allergy Clin Immunol Pract 2017;5(6):1792-1793. PubMed · DOI
  8. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. Evaluation of the risk of infection associated with subcutaneous allergen immunotherapy: American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology National Surveillance Study on Allergen Immunotherapy, 2014-2015. Ann Allergy Asthma Immunol 2017;118(4):511-512. PubMed · DOI
  9. Johansson E, Biagini Myers JM, Martin LJ, He H, Pilipenko V, Mersha T, … Bernstein DI, et al.. KIF3A genetic variation is associated with pediatric asthma in the presence of eczema independent of allergic rhinitis. J Allergy Clin Immunol 2017;140(2):595-598.e5. PubMed · DOI
  10. Kannan JA, Brokamp C, Bernstein DI, LeMasters GK, Hershey GKK, Villareal MS, et al.. Parental Snoring and Environmental Pollutants, but Not Aeroallergen Sensitization, Are Associated with Childhood Snoring in a Birth Cohort. Pediatr Allergy Immunol Pulmonol 2017;30(1):31-38. PubMed · DOI
  11. Matsuoka T, Bernstein DI, Masuyama K, Nolte H, Okamiya K, Seitzberg D, et al.. Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents. Pediatr Allergy Immunol 2017;28(7):661-667. PubMed · DOI
  12. Brunton S, Nelson HS, Bernstein DI, Lawton S, Lu S, Nolte H. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma. Postgrad Med 2017;129(6):581-589. PubMed · DOI
  13. Greenhawt M, Oppenheimer J, Nelson M, Nelson H, Lockey R, Lieberman P, … Bernstein DI, et al.. Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol 2017;118(3):276-282.e2. PubMed · DOI
  14. Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, … Bernstein DI, et al.. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol 2017;119(6):489-511.e41. PubMed · DOI

2016

  1. Bernstein DI, Schwartz G, Bernstein JA. Allergic Rhinitis: Mechanisms and Treatment. Immunol Allergy Clin North Am 2016;36(2):261-78. PubMed · DOI
  2. Sabbioni G, Vanimireddy LR, Lummus ZL, Bernstein DI. Comparison of biological effects with albumin adducts of 4,4'-methylenediphenyl diisocyanate in workers. Arch Toxicol 2016;91(4):1809-1814. PubMed · DOI
  3. Creticos PS, Bernstein DI, Casale TB, Lockey RF, Maloney J, Nolte H. Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review. J Allergy Clin Immunol Pract 2016;4(6):1194-1204.e4. PubMed · DOI
  4. Nolte H, Bernstein DI, Nelson HS, Kleine-Tebbe J, Sussman GL, Seitzberg D, et al.. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2016;138(6):1631-1638. PubMed · DOI
  5. Weiler JM, Brannan JD, Randolph CC, Hallstrand TS, Parsons J, Silvers W, … Bernstein DI, et al.. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016;138(5):1292-1295.e36. PubMed · DOI
  6. Zieglmayer P, Nolte H, Nelson HS, Bernstein DI, Kaur A, Jacobi H, et al.. Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial. Ann Allergy Asthma Immunol 2016;117(6):690-696.e1. PubMed · DOI
  7. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013). Ann Allergy Asthma Immunol 2016;116(4):354-359.e2. PubMed · DOI
  8. Bernstein DI, Gillespie M, Song S, Steinfeld J. Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study. J Asthma 2016;54(6):559-569. PubMed · DOI
  9. Maloney J, Berman G, Gagnon R, Bernstein DI, Nelson HS, Kleine-Tebbe J, et al.. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated. J Allergy Clin Immunol Pract 2016;4(2):301-9.e2. PubMed · DOI
  10. Fitzhugh DJ, Bernstein DI. Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?. J Allergy Clin Immunol Pract 2016;4(5):862-7. PubMed · DOI
  11. Zhang Z, Biagini Myers JM, Brandt EB, Ryan PH, Lindsey M, Mintz-Cole RA, … Bernstein DI, et al.. β-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant T2/T17 responses. J Allergy Clin Immunol 2016;139(1):54-65.e8. PubMed · DOI

2015

  1. Bernstein DI. Contact Dermatitis for the Practicing Allergist. J Allergy Clin Immunol Pract 2015;3(5):652-8; quiz 659-60. PubMed · DOI
  2. Fonacier L, Bernstein DI, Pacheco K, Holness DL, Blessing-Moore J, Khan D, et al.. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract 2015;3(3 Suppl):S1-39. PubMed · DOI
  3. Codispoti CD, Bernstein DI, Levin L, Reponen T, Ryan PH, Biagini Myers JM, et al.. Early-life mold and tree sensitivity is associated with allergic eosinophilic rhinitis at 4 years of age. Ann Allergy Asthma Immunol 2015;114(3):193-198.e4. PubMed · DOI
  4. Brandt EB, Biagini Myers JM, Acciani TH, Ryan PH, Sivaprasad U, Ruff B, … Bernstein DI, et al.. Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibility. J Allergy Clin Immunol 2015;136(2):295-303.e7. PubMed · DOI
  5. Bernstein DI, Bateman ED, Woodcock A, Toler WT, Forth R, Jacques L, et al.. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma. J Asthma 2015;52(10):1073-83. PubMed · DOI
  6. Yucesoy B, Kashon ML, Johnson VJ, Lummus ZL, Fluharty K, Gautrin D, … Bernstein DI, et al.. Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma. J Immunotoxicol 2015;13(1):119-26. PubMed · DOI
  7. Yucesoy B, Kaufman KM, Lummus ZL, Weirauch MT, Zhang G, Cartier A, … Bernstein DI, et al.. Genome-Wide Association Study Identifies Novel Loci Associated With Diisocyanate-Induced Occupational Asthma. Toxicol Sci 2015;146(1):192-201. PubMed · DOI
  8. Yucesoy B, Kissling GE, Johnson VJ, Lummus ZL, Gautrin D, Cartier A, … Bernstein DI, et al.. N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma. J Occup Environ Med 2015;57(12):1331-6. PubMed · DOI
  9. Nolte H, Maloney J, Nelson HS, Bernstein DI, Lu S, Li Z, et al.. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. J Allergy Clin Immunol 2015;135(6):1494-501.e6. PubMed · DOI
  10. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, … Bernstein DI, et al.. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 2015;136(5):1186-205.e1-78. PubMed · DOI
  11. Maloney J, Prenner BM, Bernstein DI, Lu S, Gawchik S, Berman G, et al.. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites. Ann Allergy Asthma Immunol 2015;116(1):59-65. PubMed · DOI
  12. Kannan JA, Bernstein DI, Bernstein CK, Ryan PH, Bernstein JA, Villareal MS, et al.. Significant predictors of poor quality of life in older asthmatics. Ann Allergy Asthma Immunol 2015;115(3):198-204. PubMed · DOI
  13. Li JT, Bernstein DI, Calderon MA, Casale TB, Cox L, Passalacqua G, et al.. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report. J Allergy Clin Immunol 2015;137(2):369-76. PubMed · DOI

2014

  1. Calderon MA, Bernstein DI, Blaiss M, Andersen JS, Nolte H. A comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis. Clin Exp Allergy 2014;44(10):1228-39. PubMed · DOI
  2. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract 2014;2(2):161-7. PubMed · DOI
  3. Bousquet J, Gern JE, Martinez FD, Anto JM, Johnson CC, Holt PG, … Bernstein DI, et al.. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol 2014;133(6):1535-46. PubMed · DOI
  4. Cheng G, Smith AM, Levin L, Epstein T, Ryan PH, LeMasters GK, … Bernstein DI, et al.. Duration of day care attendance during infancy predicts asthma at the age of seven: the Cincinnati Childhood Allergy and Air Pollution Study. Clin Exp Allergy 2014;44(10):1274-81. PubMed · DOI
  5. Biagini Myers JM, Martin LJ, Kovacic MB, Mersha TB, He H, Pilipenko V, … Bernstein DI, et al.. Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma. J Allergy Clin Immunol 2014;134(4):891-899.e3. PubMed · DOI
  6. Yucesoy B, Johnson VJ, Lummus ZL, Kashon ML, Rao M, Bannerman-Thompson H, … Bernstein DI, et al.. Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma. J Occup Environ Med 2014;56(4):382-7. PubMed · DOI
  7. Durham SR, Nelson HS, Nolte H, Bernstein DI, Creticos PS, Li Z, et al.. Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure. Allergy 2014;69(5):617-23. PubMed · DOI
  8. LeMasters GK, Khurana Hershey GK, Sivaprasad U, Martin LJ, Pilipenko V, Ericksen MB, … Bernstein DI, et al.. N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort. Pharmacogenomics J 2014;15(2):189-95. PubMed · DOI
  9. Amin P, Levin L, Epstein T, Ryan P, LeMasters G, Khurana Hershey G, … Bernstein DI, et al.. Optimum predictors of childhood asthma: persistent wheeze or the Asthma Predictive Index?. J Allergy Clin Immunol Pract 2014;2(6):709-15. PubMed · DOI
  10. Nolte H, Amar N, Bernstein DI, Lanier BQ, Creticos P, Berman G, et al.. Safety and tolerability of a short ragweed sublingual immunotherapy tablet. Ann Allergy Asthma Immunol 2014;113(1):93-100.e3. PubMed · DOI
  11. LeMasters G, Levin L, Bernstein DI, Lockey SD, Lockey JE, Burkle J, et al.. Secondhand smoke and traffic exhaust confer opposing risks for asthma in normal and overweight children. Obesity (Silver Spring) 2014;23(1):32-6. PubMed · DOI
  12. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, … Bernstein DI, et al.. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 2014;133(5):1270-7. PubMed · DOI
  13. Codispoti CD, LeMasters GK, Levin L, Reponen T, Ryan PH, Biagini Myers JM, … Bernstein DI, et al.. Traffic pollution is associated with early childhood aeroallergen sensitization. Ann Allergy Asthma Immunol 2014;114(2):126-33. PubMed · DOI

2013

  1. Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, … Bernstein DI, et al.. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol 2013;131(6):1491-3. PubMed · DOI
  2. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?. Ann Allergy Asthma Immunol 2013;110(4):274-8, 278.e1. PubMed · DOI
  3. Bernstein DI. An alternative approach to the chronic refractory cough?. J Allergy Clin Immunol Pract 2013;1(6):707-8. PubMed · DOI
  4. Epstein TG, Kesavalu B, Bernstein CK, Ryan PH, Bernstein JA, Zimmermann N, … Bernstein DI, et al.. Chronic traffic pollution exposure is associated with eosinophilic, but not neutrophilic inflammation in older adult asthmatics. J Asthma 2013;50(9):983-9. PubMed · DOI
  5. Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, et al.. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol 2013;112(2):146-153.e2. PubMed · DOI
  6. Rank MA, Bernstein DI. Improving the safety of immunotherapy. J Allergy Clin Immunol Pract 2013;2(2):131-5. PubMed · DOI
  7. Ouyang B, Bernstein DI, Lummus ZL, Ying J, Boulet LP, Cartier A, et al.. Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma. Toxicol Sci 2013;133(2):218-24. PubMed · DOI
  8. Bernstein DI. Management of the individual worker with occupational asthma. Ann Allergy Asthma Immunol 2013;111(3):167-9. PubMed · DOI
  9. Johansson E, Reponen T, Vesper S, Levin L, Lockey J, Ryan P, … Bernstein DI, et al.. Microbial content of household dust associated with exhaled NO in asthmatic children. Environ Int 2013;59:141-7. PubMed · DOI
  10. Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy 2013;27(2):102-8. PubMed · DOI
  11. Creticos PS, Maloney J, Bernstein DI, Casale T, Kaur A, Fisher R, et al.. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013;131(5):1342-9.e6. PubMed · DOI

2012

  1. Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, et al.. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012;130(1):25-43. PubMed · DOI
  2. Biagini Myers JM, Khurana Hershey GK, Deka R, Burkle JW, Levin LS, Bernstein DI, et al.. Asking the right questions to ascertain early childhood secondhand smoke exposures. J Pediatr 2012;160(6):1050-1. PubMed · DOI
  3. Smith AM, Villareal M, Bernstein DI, Swikert DJ. Asthma in the elderly: risk factors and impact on physical function. Ann Allergy Asthma Immunol 2012;108(5):305-10. PubMed · DOI
  4. Bernstein DI, Kashon M, Lummus ZL, Johnson VJ, Fluharty K, Gautrin D, et al.. CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci 2012;131(1):242-6. PubMed · DOI
  5. Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, et al.. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. J Allergy Clin Immunol 2012;130(6):1327-34.e1. PubMed · DOI
  6. Bernstein DI. Diesel exhaust exposure, wheezing and sneezing. Allergy Asthma Immunol Res 2012;4(4):178-83. PubMed · DOI
  7. Bernstein DI, Teper A, Gopalan G, Gates D. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2012;108(5):359-62. PubMed · DOI
  8. Portnoy J, Kennedy K, Sublett J, Phipatanakul W, Matsui E, Barnes C, … Bernstein DI, et al.. Environmental assessment and exposure control: a practice parameter--furry animals. Ann Allergy Asthma Immunol 2012;108(4):223.e1-15. PubMed · DOI
  9. Yucesoy B, Johnson VJ, Lummus ZL, Kissling GE, Fluharty K, Gautrin D, … Bernstein DI, et al.. Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma. Toxicol Sci 2012;129(1):166-73. PubMed · DOI
  10. Epstein TG, LeMasters GK, Bernstein DI, Ericksen MB, Martin LJ, Ryan PH, et al.. Genetic variation in small proline rich protein 2B as a predictor for asthma among children with eczema. Ann Allergy Asthma Immunol 2012;108(3):145-50. PubMed · DOI
  11. Reponen T, Lockey J, Bernstein DI, Vesper SJ, Levin L, Khurana Hershey GK, et al.. Infant origins of childhood asthma associated with specific molds. J Allergy Clin Immunol 2012;130(3):639-644.e5. PubMed · DOI
  12. Epstein TG, Ryan PH, LeMasters GK, Bernstein CK, Levin LS, Bernstein JA, … Bernstein DI, et al.. Poor asthma control and exposure to traffic pollutants and obesity in older adults. Ann Allergy Asthma Immunol 2012;108(6):423-428.e2. PubMed · DOI
  13. Bernstein DI. Traffic-related pollutants and wheezing in children. J Asthma 2012;49(1):5-7. PubMed · DOI
  14. Brunst KJ, Ryan PH, Lockey JE, Bernstein DI, McKay RT, Khurana Hershey GK, et al.. Unraveling the relationship between aeroallergen sensitization, gender, second-hand smoke exposure, and impaired lung function. Pediatr Allergy Immunol 2012;23(5):479-87. PubMed · DOI
  15. Kim H, Levin L, LeMasters GK, Villareal M, Evans S, Lockey JE, … Bernstein DI, et al.. Validating childhood symptoms with physician-diagnosed allergic rhinitis. Ann Allergy Asthma Immunol 2012;108(4):228-31. PubMed · DOI

2011

  1. Bernstein IL, Bernstein DI, Lummus ZL, Bernstein JA. A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis. J Womens Health (Larchmt) 2011;20(4):643-8. PubMed · DOI
  2. Carr WW, Bernstein DI, Hampel FC, Gow JA, Williams JI, Zuraw BL, et al.. Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico. Am J Rhinol Allergy 2011;25(5):369. PubMed · DOI
  3. Greenhawt MJ, Li JT, Bernstein DI, Blessing-Moore J, Cox L, Khan D, et al.. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Ann Allergy Asthma Immunol 2011;106(1):11-6. PubMed · DOI
  4. Wilder LC, Langley RL, Middleton DC, Ernst K, Lummus ZL, Streicher RP, … Bernstein DI, et al.. Communities near toluene diisocyanate sources: an investigation of exposure and health. J Expo Sci Environ Epidemiol 2011;21(6):587-94. PubMed · DOI
  5. Bernstein DI, Blaiss MS, Cox LS, Finegold I, Lanier BQ, Nelson HS, et al.. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist. Ann Allergy Asthma Immunol 2011;107(5):422-5. PubMed · DOI
  6. Bernstein DI, Hébert J, Cheema A, Murphy KR, Chérrez-Ojeda I, Matiz-Bueno CE, et al.. Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma. Allergy Asthma Clin Immunol 2011;7(1):21. PubMed · DOI
  7. Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011;127(1):72-80, 80.e1-2. PubMed · DOI
  8. Liss GM, Murphy-Berendts K, Epstein T, Bernstein DI. Factors associated with severe versus mild immunotherapy-related systemic reactions: a case-referent study. J Allergy Clin Immunol 2011;127(5):1298-300. PubMed · DOI
  9. Bernstein DI. Genetics of occupational asthma. Curr Opin Allergy Clin Immunol 2011;11(2):86-9. PubMed · DOI
  10. Bernstein DI, Kissling GE, Khurana Hershey G, Yucesoy B, Johnson VJ, Cartier A, et al.. Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α. J Allergy Clin Immunol 2011;128(2):418-20. PubMed · DOI
  11. Reponen T, Vesper S, Levin L, Johansson E, Ryan P, Burkle J, … Bernstein DI, et al.. High environmental relative moldiness index during infancy as a predictor of asthma at 7 years of age. Ann Allergy Asthma Immunol 2011;107(2):120-6. PubMed · DOI
  12. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2. Ann Allergy Asthma Immunol 2011;107(5):426-431.e1. PubMed · DOI
  13. Bernstein DI. Occupational asthma. Preface. Immunol Allergy Clin North Am 2011;31(4):xi-xii. PubMed · DOI
  14. Sublett JW, Bernstein DI. Occupational rhinitis. Immunol Allergy Clin North Am 2011;31(4):787-96, vii. PubMed · DOI
  15. Epstein TG, Bernstein DI, Levin L, Khurana Hershey GK, Ryan PH, Reponen T, et al.. Opposing effects of cat and dog ownership and allergic sensitization on eczema in an atopic birth cohort. J Pediatr 2011;158(2):265-71.e1-5. PubMed · DOI
  16. Lummus ZL, Wisnewski AV, Bernstein DI. Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am 2011;31(4):699-716, vi. PubMed · DOI
  17. Bjornsdottir US, Holgate ST, Reddy PS, Hill AA, McKee CM, Csimma CI, … Bernstein DI, et al.. Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood. PLoS One 2011;6(7):e21902. PubMed · DOI
  18. Bernstein DI, Epstein T. Systemic reactions to subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 2011;31(2):241-9, viii-ix. PubMed · DOI

2010

  1. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, … Bernstein DI, et al.. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2010;127(1 Suppl):S1-55. PubMed · DOI
  2. Codispoti CD, Levin L, LeMasters GK, Ryan P, Reponen T, Villareal M, … Bernstein DI, et al.. Breast-feeding, aeroallergen sensitization, and environmental exposures during infancy are determinants of childhood allergic rhinitis. J Allergy Clin Immunol 2010;125(5):1054-1060.e1. PubMed · DOI
  3. Prenner BM, Lanier BQ, Bernstein DI, Shekar T, Teper A. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2010;125(6):1247-1253.e5. PubMed · DOI
  4. Sublett JW, Bernstein DI. Occupational rhinitis. Curr Allergy Asthma Rep 2010;10(2):99-104. PubMed · DOI
  5. Weiler JM, Anderson SD, Randolph C, Bonini S, Craig TJ, Pearlman DS, … Bernstein DI, et al.. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105(6 Suppl):S1-47. PubMed · DOI
  6. Bernstein DI, Epstein T, Murphy-Berendts K, Liss GM. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol 2010;104(6):530-5. PubMed · DOI
  7. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al.. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010;126(3):477-80.e1-42. PubMed · DOI

2009

  1. Berger WE, Kerwin E, Bernstein DI, Pedinoff A, Bensch G, Karafilidis J. Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids. Allergy Asthma Proc 2009;30(3):304-14. PubMed · DOI
  2. Ryan PH, Bernstein DI, Lockey J, Reponen T, Levin L, Grinshpun S, et al.. Exposure to traffic-related particles and endotoxin during infancy is associated with wheezing at age 3 years. Am J Respir Crit Care Med 2009;180(11):1068-75. PubMed · DOI
  3. Biagini Myers JM, Wang N, LeMasters GK, Bernstein DI, Epstein TG, Lindsey MA, et al.. Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohort. J Invest Dermatol 2009;130(2):430-7. PubMed · DOI
  4. Smith AM, Bernstein DI. Management of work-related asthma. J Allergy Clin Immunol 2009;123(3):551-7. PubMed · DOI
  5. Iossifova YY, Reponen T, Ryan PH, Levin L, Bernstein DI, Lockey JE, et al.. Mold exposure during infancy as a predictor of potential asthma development. Ann Allergy Asthma Immunol 2009;102(2):131-7. PubMed · DOI

2008

  1. Bernstein DI. ABCs of Asthma. Clin Cornerstone 2008;8(4):9-25. PubMed · DOI
  2. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al.. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008;100(3 Suppl 3):S1-148. PubMed · DOI
  3. Schroer KT, Biagini Myers JM, Ryan PH, LeMasters GK, Bernstein DI, Villareal M, et al.. Associations between multiple environmental exposures and Glutathione S-Transferase P1 on persistent wheezing in a birth cohort. J Pediatr 2008;154(3):401-8, 408.e1. PubMed · DOI
  4. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al.. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl):S1-84. PubMed · DOI

2007

  1. Rezvani M, Bernstein DI. Anaphylactic reactions during immunotherapy. Immunol Allergy Clin North Am 2007;27(2):295-307, viii. PubMed · DOI
  2. Campo P, Wisnewski AV, Lummus Z, Cartier A, Malo JL, Boulet LP, … Bernstein DI, et al.. Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI-exposed workers. Clin Exp Allergy 2007;37(7):1095-102. PubMed · DOI
  3. Smith AM, Bernstein DI, LeMasters GK, Huey NL, Ericksen M, Villareal M, et al.. Environmental tobacco smoke and interleukin 4 polymorphism (C-589T) gene: environment interaction increases risk of wheezing in African-American infants. J Pediatr 2007;152(5):709-15, 715.e1. PubMed · DOI
  4. Bernstein DI, Allen DB. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. Ann Allergy Asthma Immunol 2007;98(2):118-27. PubMed · DOI
  5. Iossifova YY, Reponen T, Bernstein DI, Levin L, Kalra H, Campo P, et al.. House dust (1-3)-beta-D-glucan and wheezing in infants. Allergy 2007;62(5):504-13. PubMed · DOI
  6. Smith AM, Amin HS, Biagini RE, Hamilton RG, Arif SA, Yeang HY, … Bernstein DI, et al.. Percutaneous reactivity to natural rubber latex proteins persists in health-care workers following avoidance of natural rubber latex. Clin Exp Allergy 2007;37(9):1349-56. PubMed · DOI

2006

  1. Ryan PH, Lemasters GK, Biswas P, Levin L, Hu S, Lindsey M, … Bernstein DI, et al.. A comparison of proximity and land use regression traffic exposure models and wheezing in infants. Environ Health Perspect 2006;115(2):278-84. PubMed · DOI
  2. Yeang HY, Hamilton RG, Bernstein DI, Arif SA, Chow KS, Loke YH, et al.. Allergen concentration in natural rubber latex. Clin Exp Allergy 2006;36(8):1078-86. PubMed · DOI
  3. Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, et al.. Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol 2006;97(6):800-6. PubMed · DOI
  4. Biagini JM, LeMasters GK, Ryan PH, Levin L, Reponen T, Bernstein DI, et al.. Environmental risk factors of rhinitis in early infancy. Pediatr Allergy Immunol 2006;17(4):278-84. PubMed · DOI
  5. Bernstein DI, Ott MG, Woolhiser M, Lummus Z, Graham C. Evaluation of antibody binding to diisocyanate protein conjugates in a general population. Ann Allergy Asthma Immunol 2006;97(3):357-64. PubMed · DOI
  6. Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006;117(1):169-75. PubMed · DOI
  7. LeMasters GK, Wilson K, Levin L, Biagini J, Ryan P, Lockey JE, … Bernstein DI, et al.. High prevalence of aeroallergen sensitization among infants of atopic parents. J Pediatr 2006;149(4):505-11. PubMed · DOI
  8. Campo P, Kalra HK, Levin L, Reponen T, Olds R, Lummus ZL, … Bernstein DI, et al.. Influence of dog ownership and high endotoxin on wheezing and atopy during infancy. J Allergy Clin Immunol 2006;118(6):1271-8. PubMed · DOI
  9. Vesper SJ, McKinstry C, Haugland RA, Iossifova Y, Lemasters G, Levin L, … Bernstein DI, et al.. Relative moldiness index as predictor of childhood respiratory illness. J Expo Sci Environ Epidemiol 2006;17(1):88-94. PubMed · DOI
  10. Osborne M, Reponen T, Adhikari A, Cho SH, Grinshpun SA, Levin L, … Bernstein DI, et al.. Specific fungal exposures, allergic sensitization, and rhinitis in infants. Pediatr Allergy Immunol 2006;17(6):450-7. PubMed · DOI
  11. Cho SH, Reponen T, Bernstein DI, Olds R, Levin L, Liu X, et al.. The effect of home characteristics on dust antigen concentrations and loads in homes. Sci Total Environ 2006;371(1-3):31-43. PubMed · DOI

2005

  1. White JF, Levin L, Villareal M, Murphy K, Biagini R, Wellinghoff L, … Bernstein DI, et al.. Lack of correlation between regional pollen counts and percutaneous reactivity to tree pollen extracts in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2005;94(2):240-6. PubMed · DOI
  2. Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, et al.. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2005;95(6):600-6. PubMed · DOI

2004

  1. Campo P, Lummus ZL, Bernstein DI. Advances in methods used in evaluation of occupational asthma. Curr Opin Pulm Med 2004;10(2):142-6. PubMed · DOI
  2. Bernstein DI. The skin prick test: "more than meets the eye". Ann Allergy Asthma Immunol 2004;92(6):587-8. PubMed · DOI
  3. Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, et al.. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004;34(6):952-7. PubMed · DOI
  4. Bernstein DI, Wanner M, Borish L, Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004;113(6):1129-36. PubMed · DOI

2003

  1. Bernstein DI, Karnani R, Biagini RE, Bernstein CK, Murphy K, Berendts B, et al.. Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol 2003;90(2):209-13. PubMed · DOI
  2. Bernstein DI, Biagini RE, Karnani R, Hamilton R, Murphy K, Bernstein C, et al.. In vivo sensitization to purified Hevea brasiliensis proteins in health care workers sensitized to natural rubber latex. J Allergy Clin Immunol 2003;111(3):610-6. PubMed · DOI
  3. White JF, Bernstein DI. Key pollen allergens in North America. Ann Allergy Asthma Immunol 2003;91(5):425-35; quiz 435-6, 492. PubMed · DOI
  4. Bernstein DI. Occupational asthma caused by exposure to low-molecular-weight chemicals. Immunol Allergy Clin North Am 2003;23(2):221-34, vi. PubMed · DOI
  5. Scribner TA, Bernstein DI. Rapid venom immunotherapy update. Curr Opin Allergy Clin Immunol 2003;3(4):295-8. PubMed · DOI

2002

  1. Chervinsky P, Nelson HS, Bernstein DI, Berkowitz RA, Siegel SC. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate. Int J Clin Pract 2002;56(6):419-25. PubMed
  2. Bernstein DI, Cartier A, Côté J, Malo JL, Boulet LP, Wanner M, et al.. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002;166(4):445-50. PubMed · DOI
  3. Bernstein DI, Bernstein CK, Deng C, Murphy KJ, Bernstein IL, Bernstein JA, et al.. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study. Ann Allergy Asthma Immunol 2002;88(3):272-8. PubMed · DOI
  4. Bernstein DI. Management of natural rubber latex allergy. J Allergy Clin Immunol 2002;110(2 Suppl):S111-6. PubMed · DOI

2001

  1. Mansour M, Lanphear BP, Hornung R, Khoury J, Bernstein DI, Menrath W, et al.. A side-by-side comparison of sampling methods for settled, indoor allergens. Environ Res 2001;87(1):37-46. PubMed · DOI
  2. Bernstein JA, Bernstein IL, Bernstein DI. Allergenicity of cry9c: an unresolved issue. J Allergy Clin Immunol 2001;108(4):655-6. PubMed · DOI
  3. Boeniger MF, Lummus ZL, Biagini RE, Bernstein DI, Swanson MC, Reed C, et al.. Exposure to protein aeroallergens in egg processing facilities. Appl Occup Environ Hyg 2001;16(6):660-70. PubMed · DOI
  4. Graft DF, Bernstein DI, Goldsobel A, Meltzer EO, Portnoy J, Long J. Safety of fexofenadine in children treated for seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2001;87(1):22-6. PubMed · DOI

2000

  1. Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, … Bernstein DI, et al.. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. J Allergy Clin Immunol 2000;106(5):852-60. PubMed · DOI
  2. Bernstein DI. The natural history of adult asthma: what do we know?. Ann Allergy Asthma Immunol 2000;84(5):469-70. PubMed · DOI

1999

  1. Bernstein JA, Bernstein DI, Stauder T, Lummus Z, Bernstein IL. A cross-sectional survey of sensitization to Aspergillus oryzae-derived lactase in pharmaceutical workers. J Allergy Clin Immunol 1999;103(6):1153-7. PubMed · DOI
  2. Creticos PS, Freidhoff LR, Bernstein DI, Chu T, Khattignavong AP, Pasatiempo AM, et al.. Comparison of an inhaled corticosteroid (triamcinolone acetonide) to a long-acting bronchodilator (salmeterol), the combination, and placebo in mild-moderate adult asthmatic patients. Int Arch Allergy Immunol 1999;118(2-4):345-6. PubMed · DOI
  3. Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, et al.. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 1999;20(3):173-80. PubMed · DOI
  4. Bernstein DI, Jolly A. Current diagnostic methods for diisocyanate induced occupational asthma. Am J Ind Med 1999;36(4):459-68. PubMed · DOI
  5. Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, et al.. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Respir Med 1999;93(9):603-12. PubMed · DOI
  6. Bernstein IL, Bernstein JA, Miller M, Tierzieva S, Bernstein DI, Lummus Z, et al.. Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides. Environ Health Perspect 1999;107(7):575-82. PubMed · DOI
  7. Berkowitz RB, Bernstein DI, LaForce C, Pedinoff AJ, Rooklin AR, Damaraju CR, et al.. Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis. Allergy 1999;54(1):64-9. PubMed · DOI

1998

  1. Bernstein DI, Cohen R, Ginchansky E, Pedinoff AJ, Tinkelman DG, Winder JA. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma. J Allergy Clin Immunol 1998;101(4 Pt 1):433-8. PubMed · DOI
  2. Kaiser HB, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, et al.. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. Am J Ther 1998;5(4):245-51. PubMed · DOI
  3. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998;102(2):265-74. PubMed · DOI
  4. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS. Indirect assessment of 4,4'-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med 1998;33(5):471-7. PubMed · DOI

1997

  1. Bernstein DI. Allergic reactions to workplace allergens. JAMA 1997;278(22):1907-13. PubMed
  2. Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79(5):443-8. PubMed · DOI
  3. Bernstein IL, Bernstein DI, Bernstein JA. How does auranofin compare with methotrexate and cyclosporin as a corticosteroid-sparing agent in severe asthma?. BioDrugs 1997;8(3):205-15. PubMed · DOI
  4. Bernstein JA, Sugumaran R, Bernstein DI, Bernstein IL. Prevalence of human seminal plasma hypersensitivity among symptomatic women. Ann Allergy Asthma Immunol 1997;78(1):54-8. PubMed · DOI

1996

  1. Bernstein IL, Bernstein DI, Dubb JW, Faiferman I, Wallin B. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. J Allergy Clin Immunol 1996;98(2):317-24. PubMed · DOI
  2. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma. Toxicology 1996;111(1-3):191-206. PubMed · DOI
  3. Bernstein DI, Creticos PS, Busse WW, Cohen R, Graft DF, Howland WC, et al.. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1996;97(3):749-55. PubMed · DOI
  4. Biagini RE, Driscoll RJ, Bernstein DI, Wilcox TG, Henningsen GM, MacKenzie BA, et al.. Hypersensitivity reactions and specific antibodies in workers exposed to industrial enzymes at a biotechnology plant. J Appl Toxicol 1996;16(2):139-45. PubMed · DOI
  5. Bernstein DI. Multiple chemical sensitivity: state of the art symposium. The role of chemical allergens. Regul Toxicol Pharmacol 1996;24(1 Pt 2):S28-31. PubMed · DOI
  6. Miller ME, Lummus ZL, Bernstein DI. Occupational asthma caused by FD&C blue dye no. 2. Allergy Asthma Proc 1996;17(1):31-4. PubMed · DOI
  7. Donnelly A, Bernstein DI, Goldstein S, Grossman J, Schwartz HJ, Casale TB. Speed of onset of action of Tilarin. Allergy 1996;51(28 Suppl):14-9. PubMed · DOI

1995

  1. Kotses H, Bernstein IL, Bernstein DI, Reynolds RV, Korbee L, Wigal JK, et al.. A self-management program for adult asthma. Part I: Development and evaluation. J Allergy Clin Immunol 1995;95(2):529-40. PubMed · DOI
  2. Taitel MS, Kotses H, Bernstein IL, Bernstein DI, Creer TL. A self-management program for adult asthma. Part II: Cost-benefit analysis. J Allergy Clin Immunol 1995;95(3):672-6. PubMed · DOI
  3. Leikauf GD, Kline S, Albert RE, Baxter CS, Bernstein DI, Bernstein J, et al.. Evaluation of a possible association of urban air toxics and asthma. Environ Health Perspect 1995;103 Suppl 6(Suppl 6):253-71. PubMed · DOI
  4. Bernstein DI, Lummus ZL, Santilli G, Siskosky J, Bernstein IL. Machine operator's lung. A hypersensitivity pneumonitis disorder associated with exposure to metalworking fluid aerosols. Chest 1995;108(3):636-41. PubMed · DOI

1994

  1. Bernstein JA, Stauder T, Bernstein DI, Bernstein IL. A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines. J Allergy Clin Immunol 1994;94(2 Pt 1):257-9. PubMed · DOI
  2. Herd ZL, Bernstein DI. Antigen-specific stimulation of histamine releasing factors in diisocyanate-induced occupational asthma. Am J Respir Crit Care Med 1994;150(4):988-94. PubMed · DOI
  3. Bernstein DI, Bernstein IL, Gaines WG, Stauder T, Wilson ER. Characterization of skin prick testing responses for detecting sensitization to detergent enzymes at extreme dilutions: inability of the RAST to detect lightly sensitized individuals. J Allergy Clin Immunol 1994;94(3 Pt 1):498-507. PubMed · DOI
  4. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Ann Allergy 1994;73(5):423-8. PubMed

1993

  1. Bernstein JA, Herd ZA, Bernstein DI, Korbee L, Bernstein IL. Evaluation and treatment of localized vaginal immunoglobulin E-mediated hypersensitivity to human seminal plasma. Obstet Gynecol 1993;82(4 Pt 2 Suppl):667-73. PubMed
  2. Bernstein JA, Kraut A, Bernstein DI, Warrington R, Bolin T, Warren CP, et al.. Occupational asthma induced by inhaled egg lysozyme. Chest 1993;103(2):532-5. PubMed · DOI
  3. Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, et al.. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993;92(3):387-96. PubMed · DOI

1992

  1. Donaldson VH, Bernstein DI, Wagner CJ, Mitchell BH, Scinto J, Bernstein IL. Angioneurotic edema with acquired C1- inhibitor deficiency and autoantibody to C1- inhibitor: response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992;119(4):397-406. PubMed
  2. Bernstein DI. Occupational asthma. Med Clin North Am 1992;76(4):917-34. PubMed · DOI
  3. Monroe EW, Bernstein DI, Fox RW, Grabiec SV, Honsinger RW, Kalivas JT, et al.. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Arzneimittelforschung 1992;42(9):1119-21. PubMed
  4. Bernstein DI, Ploysongsang Y, Mittman RJ, Piyamahunt A, Bernstein IL. The relationship between airway responsiveness measured before and after the allergen-induced late asthmatic response. Chest 1992;101(2):437-41. PubMed · DOI

1990

  1. Biagini RE, Klincewicz SL, Henningsen GM, MacKenzie BA, Gallagher JS, Bernstein DI, et al.. Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci 1990;47(10):897-908. PubMed · DOI
  2. Sarlo K, Clark ED, Ryan CA, Bernstein DI. ELISA for human IgE antibody to subtilisin A (Alcalase): correlation with RAST and skin test results with occupationally exposed individuals. J Allergy Clin Immunol 1990;86(3 Pt 1):393-9. PubMed · DOI
  3. Smith AB, Bernstein DI, London MA, Gallagher J, Ornella GA, Gelletly SK, et al.. Evaluation of occupational asthma from airborne egg protein exposure in multiple settings. Chest 1990;98(2):398-404. PubMed · DOI
  4. Mittman RJ, Bernstein DI, Adler TR, Korbee L, Nath V, Gallagher JS, et al.. Selective desensitization to seminal plasma protein fractions after immunotherapy for postcoital anaphylaxis. J Allergy Clin Immunol 1990;86(6 Pt 1):954-60. PubMed · DOI

1989

  1. Bernstein DI, Mittman RJ, Kagen SL, Korbee L, Enrione M, Bernstein IL. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. J Allergy Clin Immunol 1989;84(6 Pt 1):951-9. PubMed · DOI
  2. Bernstein DI, Zeiss CR. Guidelines for preparation and characterization of chemical-protein conjugate antigens. Report of the Subcommittee on Preparation and Characterization of Low Molecular Weight Antigens. J Allergy Clin Immunol 1989;84(5 Pt 2):820-2. PubMed · DOI
  3. Bernstein DI, Cohn JR. Guidelines for the diagnosis and evaluation of occupational immunologic lung disease: preface. J Allergy Clin Immunol 1989;84(5 Pt 2):791-3. PubMed
  4. Steinberg DR, Bernstein DI, Bernstein IL, Murlas CG. Prednisone pretreatment leads to histaminic airway hyporeactivity soon after resolution of the immediate allergic response. Chest 1989;95(2):314-9. PubMed · DOI
  5. Mittman RJ, Bernstein DI, Steinberg DR, Enrione M, Bernstein IL. Progesterone-responsive urticaria and eosinophilia. J Allergy Clin Immunol 1989;84(3):304-10. PubMed · DOI

1988

  1. Bernstein IL, Bernstein DI. A 17% prevalence of anaphylaxis during chemonucleolysis among 35 patients who underwent a repeat chemonucleolysis procedure. Spine (Phila Pa 1976) 1988;13(1):135. PubMed
  2. Bernstein DI, Bernstein IL, Bodenheimer SS, Pietrusko RG. An open study of auranofin in the treatment of steroid-dependent asthma. J Allergy Clin Immunol 1988;81(1):6-16. PubMed · DOI
  3. Grant JA, Bernstein DI, Buckley CE, Chu T, Fox RW, Rocklin RE, et al.. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1988;81(3):574-9. PubMed
  4. Monroe EW, Fox RW, Green AW, Izuno GT, Bernstein DI, Pleskow WW, et al.. Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol 1988;19(1 Pt 1):138-9. PubMed · DOI
  5. Biagini RE, Bernstein DI, Gallagher JS, Moorman WJ, Knecht EA, Smallwood AW, et al.. Immune responses of cynomolgus monkeys to phthalic anhydride. J Allergy Clin Immunol 1988;82(1):23-9. PubMed · DOI
  6. Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol 1988;82(1):55-61. PubMed · DOI

1987

  1. Bernstein DI, Smith AB, Moller DR, Gallagher JS, Aw TC, London M, et al.. Clinical and immunologic studies among egg-processing workers with occupational asthma. J Allergy Clin Immunol 1987;80(6):791-7. PubMed · DOI
  2. Steinberg DR, Bernstein DI, Gallagher JS, Arlian L, Bernstein IL. Cockroach sensitization in laboratory workers. J Allergy Clin Immunol 1987;80(4):586-90. PubMed · DOI
  3. Rosenman KD, Bernstein DI, O'Leary K, Gallagher JS, D'Souza L, Bernstein IL. Occupational asthma caused by himic anhydride. Scand J Work Environ Health 1987;13(2):150-4. PubMed · DOI
  4. Smith AB, Bernstein DI, Aw TC, Gallagher JS, London M, Kopp S, et al.. Occupational asthma from inhaled egg protein. Am J Ind Med 1987;12(2):205-18. PubMed · DOI

1986

  1. Bernstein DI, Bernstein IL. Chymopapain induced allergic reactions. Clin Rev Allergy 1986;4(2):201-13. PubMed · DOI
  2. Moller DR, Brooks SM, Bernstein DI, Cassedy K, Enrione M, Bernstein IL. Delayed anaphylactoid reaction in a worker exposed to chromium. J Allergy Clin Immunol 1986;77(3):451-6. PubMed · DOI
  3. Bernstein IL, Bernstein DI. Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986;77(1 Pt 1):37-42. PubMed · DOI

1985

  1. Bernstein IL, Bernstein DI. "What's in the beef?". Ann Allergy 1985;55(4):525-6. PubMed
  2. Moller DR, Gallagher JS, Bernstein DI, Wilcox TG, Burroughs HE, Bernstein IL. Detection of IgE-mediated respiratory sensitization in workers exposed to hexahydrophthalic anhydride. J Allergy Clin Immunol 1985;75(6):663-72. PubMed · DOI
  3. Bernstein DI, Gallagher JS, Ulmer A, Bernstein IL. Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis. J Allergy Clin Immunol 1985;76(3):458-65. PubMed · DOI

1984

  1. Bernstein DI, Gallagher JS, D'Souza L, Bernstein IL. Heterogeneity of specific-IgE responses in workers sensitized to acid anhydride compounds. J Allergy Clin Immunol 1984;74(6):794-801. PubMed · DOI
  2. Bernstein DI, Gallagher JS, Grad M, Bernstein IL. Local ocular anaphylaxis to papain enzyme contained in a contact lens cleansing solution. J Allergy Clin Immunol 1984;74(3 Pt 1):258-60. PubMed · DOI
  3. Bernstein IL, Bernstein DI, Gallagher JS. Predicting anaphylaxis to chymopapain. Hosp Pract (Off Ed) 1984;19(6):28. PubMed

1983

  1. Bernstein DI, Gallagher JS, Bernstein IL. Mealworm asthma: clinical and immunologic studies. J Allergy Clin Immunol 1983;72(5 Pt 1):475-80. PubMed · DOI
  2. Bernstein DI, Roach DE, McGrath KG, Larsen RS, Zeiss CR, Patterson R. The relationship of airborne trimellitic anhydride concentrations to trimellitic anhydride--induced symptoms and immune responses. J Allergy Clin Immunol 1983;72(6):709-13. PubMed · DOI
  3. Bernstein DI, Zeiss CR, Wolkonsky P, Levitz D, Roberts M, Patterson R. The relationship of total serum IgE and blocking antibody in trimellitic anhydride--induced occupational asthma. J Allergy Clin Immunol 1983;72(6):714-9. PubMed · DOI

1982

  1. Bernstein DI, Patterson R, Zeiss CR. Clinical and immunologic evaluation of trimellitic anhydride-and phthalic anhydride-exposed workers using a questionnaire with comparative analysis of enzyme-linked immunosorbent and radioimmunoassay studies. J Allergy Clin Immunol 1982;69(3):311-8. PubMed · DOI

Compiled from PubMed (National Library of Medicine), October 2026. Papers by a different Cincinnati researcher with the same name, who works in pediatric infectious diseases, have been excluded. Profiles that cite more than 300 publications also count book chapters and articles not indexed in PubMed.